Evidence map›Paper›PMID 29214388›Full record

ArticlePharmacoEconomics2018

Current UK Practices on Health Economics Analysis Plans (HEAPs): Are We Using Heaps of Them?

Melina Dritsaki, Alastair Gray, Stavros Petrou, Susan Dutton, Sarah E Lamb, Joanna C Thorn

Abstract readLetter
PubMed Publisher
In one paragraph

Article in PharmacoEconomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Melina DritsakiNuffield Department of Orthopaedic Rheumatology and Musculoskeletal Sciences, Oxford Clinical Trials Research Unit, Centre for Statistics and Medicine, University of Oxford, Oxford, UK. melina.dritsaki@ndorms.ox.ac.uk.
Alastair GrayNuffield Department of Population Health, Health Economics Research Centre, University of Oxford, Oxford, UK.
Stavros PetrouDivision of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
Susan DuttonNuffield Department of Orthopaedic Rheumatology and Musculoskeletal Sciences, Oxford Clinical Trials Research Unit, Centre for Statistics and Medicine, University of Oxford, Oxford, UK.
Sarah E LambNuffield Department of Orthopaedic Rheumatology and Musculoskeletal Sciences, Oxford Clinical Trials Research Unit, Centre for Statistics and Medicine, University of Oxford, Oxford, UK.
Joanna C ThornSchool of Social and Community Medicine, University of Bristol, Bristol, UK.

Funding

Medical Research Council G0501681Medical Research Council G0700452Medical Research Council MR/K025643/1Medical Research Council MR/L004933/1Medical Research Council MR/L004933/2
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Costs and Cost AnalysisHumansRandomized Controlled Trials as TopicTechnology Assessment, BiomedicalUnited Kingdom

Identifiers

PMID29214388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.